142 related articles for article (PubMed ID: 36735774)
1. Noncanonical splicing junctions between exons and transposable elements represent a source of immunogenic recurrent neo-antigens in patients with lung cancer.
Merlotti A; Sadacca B; Arribas YA; Ngoma M; Burbage M; Goudot C; Houy A; Rocañín-Arjó A; Lalanne A; Seguin-Givelet A; Lefevre M; Heurtebise-Chrétien S; Baudon B; Oliveira G; Loew D; Carrascal M; Wu CJ; Lantz O; Stern MH; Girard N; Waterfall JJ; Amigorena S
Sci Immunol; 2023 Feb; 8(80):eabm6359. PubMed ID: 36735774
[TBL] [Abstract][Full Text] [Related]
2. Epigenetically controlled tumor antigens derived from splice junctions between exons and transposable elements.
Burbage M; Rocañín-Arjó A; Baudon B; Arribas YA; Merlotti A; Rookhuizen DC; Heurtebise-Chrétien S; Ye M; Houy A; Burgdorf N; Suarez G; Gros M; Sadacca B; Carrascal M; Garmilla A; Bohec M; Baulande S; Lombard B; Loew D; Waterfall JJ; Stern MH; Goudot C; Amigorena S
Sci Immunol; 2023 Feb; 8(80):eabm6360. PubMed ID: 36735776
[TBL] [Abstract][Full Text] [Related]
3. CD8
Lee SW; Choi HY; Lee GW; Kim T; Cho HJ; Oh IJ; Song SY; Yang DH; Cho JH
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34593620
[TBL] [Abstract][Full Text] [Related]
4. Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma.
Gjerstorff MF; Pøhl M; Olsen KE; Ditzel HJ
BMC Cancer; 2013 Oct; 13():466. PubMed ID: 24103781
[TBL] [Abstract][Full Text] [Related]
5. Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer.
Malentacchi F; Simi L; Nannelli C; Andreani M; Janni A; Pastorekova S; Orlando C
Lung Cancer; 2009 Jun; 64(3):271-6. PubMed ID: 19022520
[TBL] [Abstract][Full Text] [Related]
6. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma.
Lee LN; Kuo SH; Lee YC; Chang YL; Chang HC; Jan IS; Yang PC
J Formos Med Assoc; 2005 Aug; 104(8):541-8. PubMed ID: 16193174
[TBL] [Abstract][Full Text] [Related]
7. Detection of tumor antigens and tumor-antigen specific T cells in NSCLC patients: Correlation of the quality of T cell responses with NSCLC subtype.
Palata O; Podzimkova Hradilova N; Mysiková D; Kutna B; Mrazkova H; Lischke R; Spisek R; Adkins I
Immunol Lett; 2020 Mar; 219():46-53. PubMed ID: 31931024
[TBL] [Abstract][Full Text] [Related]
8. Endogenous CD4
Veatch JR; Jesernig BL; Kargl J; Fitzgibbon M; Lee SM; Baik C; Martins R; Houghton AM; Riddell SR
Cancer Immunol Res; 2019 Jun; 7(6):910-922. PubMed ID: 31043415
[TBL] [Abstract][Full Text] [Related]
9. Characterization of preexisting humoral immunity specific for two cancer-testis antigens overexpressed at the mRNA level in non-small cell lung cancer.
Watanabe Y; LePage S; Elliott M; Secrist H; Tanaka T; Kawahara M; Matsumura A; Hosoe S; Ogawara M; Okada M; Repasky B; Sleath P; Wang T; Henderson R
Cancer Immun; 2006 Feb; 6():3. PubMed ID: 16468707
[TBL] [Abstract][Full Text] [Related]
10. Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients.
Saito K; Nakayama E; Valmori D
PLoS One; 2016; 11(3):e0150623. PubMed ID: 26937656
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of CD4+ CD25+ regulatory T-cells detection in tumor-draining lymph nodes of nonsmall cell lung cancer patients].
Su YJ; Ren K; Li H; Ren XB; Wang CL
Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):922-6. PubMed ID: 18478932
[TBL] [Abstract][Full Text] [Related]
12. Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment.
Fehlings M; Jhunjhunwala S; Kowanetz M; O'Gorman WE; Hegde PS; Sumatoh H; Lee BH; Nardin A; Becht E; Flynn S; Ballinger M; Newell EW; Yadav M
J Immunother Cancer; 2019 Sep; 7(1):249. PubMed ID: 31511069
[TBL] [Abstract][Full Text] [Related]
13. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
[TBL] [Abstract][Full Text] [Related]
14. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients.
Ohue Y; Eikawa S; Okazaki N; Mizote Y; Isobe M; Uenaka A; Fukuda M; Old LJ; Oka M; Nakayama E
Int J Cancer; 2012 Sep; 131(5):E649-58. PubMed ID: 22109656
[TBL] [Abstract][Full Text] [Related]
16. Pan-cancer analysis identifies tumor-specific antigens derived from transposable elements.
Shah NM; Jang HJ; Liang Y; Maeng JH; Tzeng SC; Wu A; Basri NL; Qu X; Fan C; Li A; Katz B; Li D; Xing X; Evans BS; Wang T
Nat Genet; 2023 Apr; 55(4):631-639. PubMed ID: 36973455
[TBL] [Abstract][Full Text] [Related]
17. Novel antigens in non-small cell lung cancer: SP17, AKAP4, and PTTG1 are potential immunotherapeutic targets.
Mirandola L; Figueroa JA; Phan TT; Grizzi F; Kim M; Rahman RL; Jenkins MR; Cobos E; Jumper C; Alalawi R; Chiriva-Internati M
Oncotarget; 2015 Feb; 6(5):2812-26. PubMed ID: 25739119
[TBL] [Abstract][Full Text] [Related]
18. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Piattoni S; Di Carlo L; Semeraro A; Darwish S; Tofanetti FR; Stocchi L; Mihaylova Z; Bellezza G; Del Sordo R; Daddi G; Crinò L; Tonato M
J Thorac Oncol; 2008 Apr; 3(4):365-73. PubMed ID: 18379354
[TBL] [Abstract][Full Text] [Related]
19. Single-cell RNA-seq-based proteogenomics identifies glioblastoma-specific transposable elements encoding HLA-I-presented peptides.
Bonté PE; Arribas YA; Merlotti A; Carrascal M; Zhang JV; Zueva E; Binder ZA; Alanio C; Goudot C; Amigorena S
Cell Rep; 2022 Jun; 39(10):110916. PubMed ID: 35675780
[TBL] [Abstract][Full Text] [Related]
20. Human CD8 and CD4 T cell epitopes of epithelial cancer antigens.
Sato N; Nabeta Y; Kondo H; Sahara H; Hirohashi Y; Kashiwagi K; Kanaseki T; Sato Y; Rong S; Hirai I; Kamiguchi K; Tamura Y; Matsuura A; Takahashi S; Torigoe T; Ikeda H
Cancer Chemother Pharmacol; 2000; 46 Suppl():S86-90. PubMed ID: 10950155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
